Real world outcomes of biopsy-proven oncocytic neoplasm of the kidney managed by surveillance.
Flora E RodgerKeiran BrownSteve LeungJack Coode-BateJames ArmitageAnne WarrenJane HendryGrant D StewartAlexander LairdGrenville M OadesPublished in: BJUI compass (2022)
This multicentre retrospective cohort study supports the hypothesis that selected biopsy-proven oncocytic renal neoplasms can be safely managed with surveillance in the medium term. Routine renal mass biopsy may reduce surgery for benign or indolent renal tumours and the potential associated morbidity for these patients.
Keyphrases
- ultrasound guided
- fine needle aspiration
- public health
- end stage renal disease
- ejection fraction
- newly diagnosed
- minimally invasive
- chronic kidney disease
- prognostic factors
- randomized controlled trial
- type diabetes
- study protocol
- metabolic syndrome
- cross sectional
- risk assessment
- hodgkin lymphoma
- acute coronary syndrome
- double blind
- weight loss